Proteins

CSL346 (anti-VEGFB) is an antibody targeting VEGFA.

CSL346 (anti-VEGFB) is an antibody targeting VEGFA.

CSL346 (anti-VEGFB) is an antibody targeting VEGFA.

CSL346 (anti-VEGFB) is an antibody targeting VEGFA.

Rabbit anti Human CSP-C Antibody, Polyclonal, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/1000IHC: 1/50-1/100Protein FunctionCytotoxic chymotrypsin-like serine protease with preference for bulky and aromatic residues at the P1

Rabbit anti Human CSP-C Antibody, Polyclonal, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/1000IHC: 1/50-1/100Protein FunctionCytotoxic chymotrypsin-like serine protease with preference for bulky and aromatic residues at the P1

Rabbit anti Human CSP-C Antibody, Polyclonal, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/1000IHC: 1/50-1/100Protein FunctionCytotoxic chymotrypsin-like serine protease with preference for bulky and aromatic residues at the P1

Rabbit anti Human CSP-C Antibody, Polyclonal, could be used for WB, IHC and so on.ApplicationWB: 1/500-1/1000IHC: 1/50-1/100Protein FunctionCytotoxic chymotrypsin-like serine protease with preference for bulky and aromatic residues at the P1

Interleukin-2-inducible T-cell kinase (ITK) inhibitor (IC50 values are 0.1, 0.4 and 5 μM for ITK, BTK and ETK, respectively). Inhibits growth of cancer cells expressing ITK, including MOLT-4 and Jurkat cells in vitro. Induces apoptosis in Jurkat

Interleukin-2-inducible T-cell kinase (ITK) inhibitor (IC50 values are 0.1, 0.4 and 5 μM for ITK, BTK and ETK, respectively). Inhibits growth of cancer cells expressing ITK, including MOLT-4 and Jurkat cells in vitro. Induces apoptosis in Jurkat

Interleukin-2-inducible T-cell kinase (ITK) inhibitor (IC50 values are 0.1, 0.4 and 5 μM for ITK, BTK and ETK, respectively). Inhibits growth of cancer cells expressing ITK, including MOLT-4 and Jurkat cells in vitro. Induces apoptosis in Jurkat

Interleukin-2-inducible T-cell kinase (ITK) inhibitor (IC50 values are 0.1, 0.4 and 5 μM for ITK, BTK and ETK, respectively). Inhibits growth of cancer cells expressing ITK, including MOLT-4 and Jurkat cells in vitro. Induces apoptosis in Jurkat